glp-1 coverage news today insurers A Cost That's Hard to (G)u(LP-1) Down Insurance and GLP-1s: How to
Description
Losing even a modest amount of weight can significantly improve health outcomes for individuals with obesity
Cho YM, Wideman RD, Kieffer TJ
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Veteran Affairs study revealed more real-world evidence The third study I want to share is one I first discovered through Derek Thompsons journalism (former staff writer at The Atlantic )
In a study where tirzepatide was added to insulin glargine, patients with an A1C 8% reduced their insulin glargine dose by 20% when initiating tirzepatide
